Tax Implications of Selling a Veterinary Practice in 2026: An Owner’s Guide

Key takeaways

• The structure you agree to at the letter of intent — asset sale, stock sale, or a partnership with retained equity — drives your after-tax outcome far more than any tax move you make at closing.
• Goodwill is usually the biggest piece of a practice’s price, and in an asset sale it generally gets the lowest tax rate (long-term capital gains), while equipment, inventory, and a non-compete are taxed as ordinary income.
• Purchase price allocation is a negotiation, not a formula, and the split decides how much of your price lands in the low-tax bucket versus the high-tax buckets.
• A C corporation can be taxed twice on the same sale, which is why entity structure has to be reviewed years before a sale, not weeks before.
• This is educational information, not tax or legal advice. Engage your own CPA and tax attorney early; a sell-side advisor coordinates structure and runs the process, but does not replace them.

A vet I’d known for a couple of years called me one evening, pretty rattled. She’d signed a letter of intent on her practice a few weeks earlier, a number she was genuinely happy with, and her accountant had just walked her through what she’d actually keep after taxes.

The headline price hadn’t changed. The after-tax check was hundreds of thousands of dollars lighter than she’d assumed, because of how the deal had been structured in a document she’d already signed.

That conversation is the reason for this article. Most owners spend their energy worrying about tax planning at closing, when the decision that actually moves the after-tax number happened weeks earlier, the day they agreed to the deal structure.

Over the deals we’ve closed over the past four-plus years, I’ve watched this pattern enough times to stop calling it a coincidence.

Before we go further, one thing I’ll repeat several times because it matters. This is general information to help you ask better questions, not tax or legal advice.

Every situation is different, and you need your own CPA and tax attorney looking at your specific numbers. What follows is the map, not the prescription.

The short answer on how a practice sale gets taxed

Most veterinary practice sales are structured as asset sales — the buyer purchases the practice’s individual assets (equipment, client records, goodwill, the practice name) rather than your ownership shares. The total price gets split across those asset categories, and each category carries its own tax rate.

The largest piece is almost always goodwill — the intangible value of the practice above its hard assets: reputation, client relationships, location, the value of an operating practice that’s already running. In an asset sale, goodwill is generally taxed at the lower long-term capital gains rate.

Equipment, inventory, and any non-compete you sign are taxed at higher ordinary-income rates. So the after-tax outcome depends heavily on how much of the price lands in the goodwill bucket versus the others.

That split is decided by the deal structure and the purchase price allocation, both of which are negotiated, both of which are usually locked in at the letter of intent. That is the whole game, and the rest of this article walks through it.

Why the LOI, not the closing, decides your after-tax check

There’s a comforting idea floating around that you sell the practice first and do the tax planning after. It’s backwards.

By the time you reach closing, the structure is set. The letter of intent — the LOI, the short document that lays out the basic deal terms before the lawyers draft the full agreement — has already specified whether it’s an asset sale or a stock sale, roughly how the price is allocated, and how much comes as cash versus a note or rollover.

Those are the terms that drive the tax.

I tell every owner the same thing when we sit down over dinner before a process starts. The biggest tax decisions you’ll make in this whole sale are made before you sign the LOI, while everything is still negotiable.

After that, you’re mostly working at the margins.

This is why your CPA and tax attorney need to be in the room early, modeling the structures before a buyer proposes terms. Not reacting to a signed document.

The owners who keep the most are the ones who knew the after-tax difference between an asset sale and a stock sale before any buyer said a word.

Asset sale versus stock sale versus equity sale

There are three broad ways to structure the sale of a practice, and they tax very differently. Here’s how I’d lay them out for an owner.

Asset sale

In an asset sale, the buyer buys the assets and gets what’s called a stepped-up basis — a fresh, higher tax cost in those assets that they can then depreciate, lowering their own future taxes. That write-off is worth real money to a buyer, which is why most buyers, and nearly all PE-backed groups, prefer this structure.

The tax catch for you is that the price gets split across asset classes, and several of those classes are taxed as ordinary income, not capital gains. More on that split in the next section.

Asset sales are the default in this market, per the legal and tax commentary on practice transactions, including dvm360’s analysis of how practice goodwill is valued and taxed.

Stock sale

A stock sale is the buyer purchasing your ownership shares in the entity that owns the practice, inheriting the entity along with its history. For a seller, this is often the cleaner tax outcome, because more of your gain is treated as a single capital gain on the sale of your shares rather than being broken into ordinary-income pieces.

The problem is the buyer. In a stock sale the buyer can’t step up and depreciate the assets, so they’re effectively buying with after-tax dollars.

Buyers respond either by refusing the structure or by discounting the price meaningfully to make up for the lost write-offs. So a stock sale can look better on the tax line and worse on the price line, and you have to model both together.

Equity sale with rollover (the partnership model)

The third structure has become common in PE-backed deals. The buyer takes a majority stake in the practice, often 60 to 80 percent, and you keep the rest as rollover equity — a slice of ownership in the buyer’s new entity instead of taking all cash at close.

When the buyer’s platform is set up as a partnership or LLC, that rolled-over piece can often be contributed tax-deferred under IRC Section 721, meaning you don’t pay tax on it until you eventually sell it down the road. The cash portion is still taxed now.

The retained piece rides along until the buyer’s next sale event, the so-called second bite at the apple. The mechanics are technical and entity-specific, and the law firms that work these deals, including Alston & Bird and Frost Brown Todd, treat the rollover structure as one of the most carefully drafted parts of any agreement.

How the three compare

Structure	How the gain is taxed	Who tends to prefer it	Typical use
Asset sale	Price split across asset classes; goodwill at capital gains, equipment / inventory / non-compete at ordinary income	Buyers (stepped-up basis, depreciation write-offs)	The default in most practice sales, especially with PE-backed buyers
Stock sale	Generally one capital gain on the sale of shares; fewer ordinary-income pieces	Sellers (cleaner, more capital-gains treatment)	Less common; buyers often discount price or decline
Equity sale with rollover	Cash portion taxed now; rolled equity often tax-deferred under Section 721 until later sale	PE-backed buyers and sellers who want a second bite	Increasingly common in PE-backed partnership and majority-stake deals

The table is the map, not the answer. Which structure produces the best after-tax result for you depends on your entity, your basis, your state, and the price each structure can actually command.

That’s a modeling exercise for your CPA, run against the specific offers on the table.

Purchase price allocation: where the real tax negotiation happens

Inside an asset sale, the single most important tax mechanic is the purchase price allocation. This is the part most owners have never heard of, and it quietly decides a large share of their tax bill.

Here’s how it works. Under IRC Section 1060, the total price has to be split across seven asset classes, and both buyer and seller report the same split to the IRS on Form 8594.

The IRS publishes the form and its instructions, and the underlying rules sit in Section 1060 of the tax code.

Each class is taxed differently. That’s the whole reason the allocation matters.

The asset classes that get the good rate

Goodwill and going-concern value sit in the residual class, the last bucket filled, and they’re generally taxed at long-term capital gains rates — the preferential federal rate of 0, 15, or 20 percent in 2026 for assets held more than a year, well below the ordinary-income top rate of 37 percent. On most practice sales, goodwill is the biggest single number in the deal, so getting more of the price into this bucket is worth a lot.

For a high earner selling in 2026, the long-term capital gains rate tops out at 20 percent federal, per the 2026 brackets published by the Tax Foundation and Kiplinger. There may also be a 3.8 percent net investment income tax on top, depending on the situation.

The asset classes that get the bad rate

The other classes are where ordinary income hides.

Equipment and furniture trigger something called depreciation recapture. Over the years you’ve owned the practice, you wrote off the cost of that equipment against ordinary income.

When you sell it for more than its depreciated value, the IRS recaptures those past write-offs and taxes that portion as ordinary income, up to 37 percent, not at the capital gains rate.

Inventory, the drugs and supplies on your shelves, is taxed as ordinary income. And a non-compete covenant, the promise not to open a competing practice nearby, is also taxed as ordinary income to you, even though the buyer almost always wants one.

Norton Rose Fulbright’s analysis of Section 1060 allocations lays out these class-by-class differences in detail.

Why the allocation is a tug-of-war

Now the tension becomes obvious. You want more of the price in goodwill, where you pay capital gains.

The buyer wants more in equipment and other depreciable assets, where they get faster write-offs.

The allocation has to reflect defensible fair-market values, you can’t simply assign everything to goodwill, but there’s real room to negotiate inside those limits. And because the number is binding on both parties once filed on Form 8594, it has to be agreed in the deal, not assumed afterward.

This is exactly the kind of term a sell-side advisor and your tax attorney should be working in tandem on. The advisor knows what allocations the market accepts; your tax attorney knows what defends under audit.

Get it wrong and you can hand the IRS six figures that didn’t have to leave your account.

The entity question that can double your tax

Before any of the above even applies, there’s a more fundamental question: what kind of entity owns your practice? Because the answer can mean paying tax once or paying it twice.

The C corporation trap

If your practice is held inside a C corporation and you do an asset sale, the gain can be taxed twice. First the corporation pays corporate tax on the gain, 21 percent federal in 2026 plus state.

Then, when the after-tax proceeds are distributed to you as the shareholder, you pay capital gains tax again at the personal level.

Stack those two layers and the effective rate on a sale can climb past 40 percent, sometimes well past it. On a multimillion-dollar practice, the double-tax gap between a C corporation and a pass-through can run into the high six figures or more, per the tax commentary comparing C corporation and pass-through sales.

Pass-through entities are usually taxed once

An S corporation, a partnership, or an LLC taxed as either is a pass-through. The gain flows through to your personal return and is taxed once, at your individual rate.

No separate corporate layer.

That single difference is one of the largest tax variables in the whole sale, and here’s the hard part: you usually can’t fix it at closing. Converting a C corporation to an S corporation, or unwinding a structure, takes time and carries its own rules and waiting periods.

This is why I push owners to have their CPA review entity structure years before a sale, not in the final weeks. Of everything in this article, this is the one I’d want you to check first.

Installment sales: spreading the tax over time

Not every dollar of your price arrives on closing day. Some deals pay part of the price through a seller note over several years, or through an earnout tied to future performance.

When payments land across more than one year, an installment sale may apply — recognizing the capital gain as you collect the cash, under IRC Section 453, rather than paying all the tax up front.

The appeal is straightforward. Instead of a single large gain in the year of sale, you spread the recognition across the years you actually receive the money, which can keep you in lower brackets and aligns the tax with the cash.

The IRS describes the mechanics in Publication 537.

There are two limits worth knowing before you get attached to the idea.

First, depreciation recapture can’t be deferred. Under Section 453(i), the ordinary-income recapture on your equipment is taxed in full in the year of the sale, no matter when you collect the rest.

So the installment method spreads the capital gain, not the recapture.

Second, deferring tax means carrying risk. Money you haven’t collected yet is money that depends on the buyer staying solvent and the practice performing.

An installment sale doesn’t reduce the total tax, it reschedules it, and you take on collection risk in exchange. Whether that trade makes sense is a question for your tax advisor against your own risk tolerance.

Earnouts, rollover, and the cash you can actually spend

This is where the structure and the tax meet the real world. A PE-backed offer rarely pays the whole headline number as cash at close.

It’s usually a mix: cash at close, an earnout (part of the price paid later, only if the practice hits agreed performance targets after closing), possibly a seller note, and often rollover equity.

Each piece taxes differently and arrives on a different timeline. The cash at close is taxed now under whatever structure you chose.

The earnout and seller note may qualify for installment treatment. The rollover equity, if the platform is a partnership, may be tax-deferred under Section 721 until you sell it.

The trap is anchoring to the headline. A high headline with a thin cash-at-close component and an aggressive earnout can leave you with less spendable, after-tax money than a lower headline that pays more in cash.

The tax treatment of each component is part of comparing offers honestly, and it’s a big reason the structure conversation has to happen with eyes open.

When I walk an owner through competing offers, we don’t just compare the top-line numbers. We look at what’s actually cash, what’s contingent, when each piece is taxed, and what’s left after tax.

That after-tax, risk-adjusted number is the one that matters.

State taxes and the regulatory layer

Federal tax is only part of the picture. State income tax varies enormously, and on a large sale the difference between a high-tax state and a no-income-tax state can be substantial.

Where you live, and sometimes where the practice operates, affects what you keep. That’s another reason a one-size answer doesn’t exist, and your CPA’s state-specific modeling matters.

There’s also a regulatory layer that didn’t exist a few years ago. Several states have tightened corporate practice of medicine rules — the state laws that restrict who can own or control medical and veterinary practices — which shapes how PE-backed deals can be structured, including how rollover equity and ownership are arranged.

New York’s Assembly Bill 9042 and North Carolina’s Senate Bill 570 are examples, and the legal analysis from Dechert and Holland & Knight covers the practical implications.

These laws don’t directly set your tax bill. But because they change how a deal can be structured, and structure drives tax, they’re part of why the structure conversation in a regulated state needs experienced legal and tax help on your side.

Three scenarios, three very different tax stories

Abstract rules are hard to feel. Here’s how the structure choice plays out across three situations I see regularly.

These are general patterns, not specific deals, and the numbers are directional to show the mechanics, not promises.

A $3 million PE-backed sale

A solid multi-doctor practice sells to a PE-backed group for around $3 million. The buyer wants an asset sale for the write-offs, and the owner holds the practice in an S corporation, so it’s a single layer of tax.

The tax story here turns almost entirely on the allocation. If most of the $3 million lands in goodwill, the bulk is taxed at capital gains rates.

If the buyer succeeds in pushing a large slice into equipment and a non-compete, a meaningful chunk gets taxed as ordinary income instead, and the after-tax check shrinks. Same headline price, materially different outcome, decided by a negotiation most sellers don’t know is happening.

An $8 million multi-location practice

A larger, multi-location practice sells for around $8 million. Now the stakes on every structural choice are bigger, and the entity question can be decisive.

If this practice sits inside a C corporation, the double-tax exposure on an asset sale is severe enough that the owner and their advisors may spend serious effort restructuring well ahead of the sale, or modeling whether a stock sale at a discounted price still nets more after tax. At this size, part of the price often comes as a seller note or earnout, which opens the installment-sale conversation, with the reminder that recapture is still due up front.

The order of magnitude of the tax differences here is why the planning starts years out.

A partnership with retained equity

An owner sells a majority stake to a PE-backed platform, takes cash on most of it, and rolls the rest into the new partnership entity. The cash portion is taxed now.

The rolled equity, structured under Section 721, defers tax until the eventual second sale.

This owner gets liquidity today, stays invested in the upside, and pushes part of the tax into the future. It’s an elegant structure when it fits.

It’s also one of the most technically demanding to get right, and the tax-deferred treatment depends on details that have to be confirmed by a tax attorney before signing, not hoped for afterward.

Where the biggest after-tax gains actually come from

Here’s the part that ties tax back to everything else we do. You can do every structural move right, optimize the allocation, pick the best entity treatment, use installment and rollover where they fit, and still leave the largest amount of money on the table if the price itself is too low.

The after-tax check is the sale price, minus the tax. Tax planning works on the second term.

The sale price works on the first, and the first is bigger.

A direct, single-bidder offer from one private equity buyer typically comes in meaningfully lower than what the same practice clears through a competitive process. Per Octus’s 2025 sector research, multiples for typical private veterinary practices were “lingering in the mid- to high single digits” in single-bidder contexts, while a structured process with multiple qualified bidders consistently produces a higher number.

The gap on a meaningful practice runs well into seven figures.

That’s the work of the Elite Selling System. We hand-select and vet every buyer who gets to bid on your practice, the way a doorman with a velvet rope lets in only the right people, then run a private competitive window inside that vetted group.

A higher clearing price raises the base that all your tax planning gets applied to. Optimizing the tax on a number that’s a multiple or two too low is winning the small argument and losing the big one.

So the right sequence is both, in order: run a process that maximizes the price, and structure that price to keep as much of it after tax as possible. The two together are how you keep the most.

What to do next

If you’re inside the couple of years before you sell, there are a few moves that mostly determine your tax outcome, and almost all of them happen before a buyer is even in the conversation.

Get your CPA to review your entity structure now, while there’s still time to change it if that makes sense. Have your tax advisor model the asset-versus-stock difference for your specific situation, so you know the after-tax math before any LOI.

And line up a tax attorney who has done practice transactions, so the allocation and any rollover are drafted correctly the first time.

None of that replaces what a sell-side advisor does, and a sell-side advisor doesn’t replace any of that. The cleanest outcomes I’ve seen come from the advisor and the owner’s own CPA and tax attorney working together early, the advisor maximizing and structuring the price, the tax professionals making sure the owner keeps as much of it as the law allows.

Get a Free Practice Value Estimate →

When we estimate what your practice would clear, we pull your numbers, normalize the EBITDA properly, identify the right pool of buyers for your profile, and send you back a defensible value range with the math behind it. We also coordinate the deal structure with your tax advisors so the price we work to maximize is the price you actually get to keep.

The estimate is free and there’s no obligation. The Transitions Elite engagement model is success-based, with no upfront fees and no retainer, so we’re paid only when a deal closes, and only out of the value our process delivers above what you’d have realized on your own.

---

Further reading

These are the related TE resources I’d point any vet considering a sale toward. Each one goes deep on a single piece of the decision.

• How much private equity is paying for veterinary practices — the PE business model and the four components of any PE-backed offer, including how cash, earnout, and rollover differ.
• Veterinary practice EBITDA multiples — what practices actually sell for in 2026 and the variables that move the multiple.
• How to sell a veterinary practice — the 7-step process from advisor engagement to closing, including where tax planning fits.
• Veterinary practice consolidators directory — the verified directory of major PE-backed and strategic buyers operating in 2026.
• Our practice sale results — outcomes across the practices we’ve represented.
• About Transitions Elite — the team, the methodology, and the firm’s track record.

Frequently asked questions

How is the sale of a veterinary practice taxed in 2026?

Most veterinary practice sales are structured as asset sales, where the purchase price is split across asset categories that each carry their own tax rate. Goodwill, usually the largest piece of the price, is generally taxed at long-term capital gains rates (0, 15, or 20 percent federal in 2026, plus a possible 3.8 percent net investment income tax).

Equipment triggers depreciation recapture taxed as ordinary income up to 37 percent, inventory is ordinary income, and a non-compete covenant is ordinary income. The structure chosen at letter of intent decides how much of your price lands in the low-tax goodwill bucket versus the high-tax ordinary-income buckets.

This is general information, not tax advice; engage your own CPA and tax attorney.

What is the difference between an asset sale and a stock sale for a vet practice?

In an asset sale the buyer purchases specific assets and gets a stepped-up tax basis they can depreciate, which is why most buyers prefer it. In a stock sale the buyer purchases your ownership shares and inherits the entity, including its tax history and liabilities.

Stock sales are often cleaner for the seller because more of the gain is taxed at capital gains rates, but buyers resist them because they cannot write off the purchase price, so they typically discount the price or refuse the structure. The right answer depends on your entity type and should be modeled by your tax advisor before you sign a letter of intent.

Is goodwill from a veterinary practice sale taxed as capital gains?

Generally yes, when the goodwill is held for more than a year. Under IRC Section 1060, goodwill and going-concern value sit in the residual asset class and are taxed at long-term capital gains rates rather than ordinary income.

Because goodwill is usually the biggest component of a practice’s value, how much of the total price is allocated to goodwill versus to equipment, inventory, and a non-compete has a large effect on the after-tax outcome. The allocation is negotiated and reported by both parties on IRS Form 8594.

How does purchase price allocation affect taxes on a practice sale?

Purchase price allocation divides the total price across seven asset classes defined by IRC Section 1060. Each class carries a different tax rate, so the allocation is effectively a negotiation over who pays what tax.

Sellers prefer more allocation to goodwill (capital gains) and less to equipment (depreciation recapture taxed as ordinary income), inventory (ordinary income), and a non-compete (ordinary income). Buyers prefer the opposite because depreciable assets give them faster write-offs.

The agreed allocation is binding on both parties and filed on Form 8594, so it has to be negotiated, not assumed.

Can I spread the tax on my veterinary practice sale over several years?

Sometimes, through an installment sale under IRC Section 453. If you receive payments across more than one year, such as through a seller note or an earnout, the capital gain on those deferred payments can be recognized as the cash is collected rather than all in the year of sale.

The important limit is that depreciation recapture cannot be deferred; under Section 453(i) it is taxed in full in the year of the sale regardless of when you collect. Installment treatment also does not eliminate tax, it spreads it, and it carries collection risk on the deferred balance.

A tax advisor should model whether it helps your specific situation.

How is rollover equity taxed when selling to a private equity buyer?

Rollover equity is the slice of ownership a seller keeps in the buyer’s new entity instead of taking all cash. When the buyer’s platform is structured as a partnership or LLC, the rolled portion can often be contributed tax-deferred under IRC Section 721, meaning no tax is due on that piece until the seller eventually sells it, often at the buyer’s next sale event.

The cash portion of the deal is still taxed at closing. Rollover structure is highly technical and entity-dependent, so the tax treatment has to be confirmed by your tax attorney before you agree to it.

Why does selling through a C corporation cost more tax than an S corporation or LLC?

A C corporation that sells its assets is taxed twice: once at the corporate level (21 percent federal in 2026, plus state) on the gain, and again at the shareholder level when the after-tax proceeds are distributed. A pass-through entity such as an S corporation, partnership, or LLC is generally taxed once, at the individual owner’s rate.

The gap can be very large on a multimillion-dollar sale. Entity structure cannot usually be fixed at closing, which is why it should be reviewed with a CPA years before a sale, not weeks before.

Do I need a CPA and a tax attorney to sell my veterinary practice?

Yes. The tax outcome of a practice sale turns on entity structure, purchase price allocation, deal structure, and state law, all of which require professional advice specific to your situation.

A sell-side advisor coordinates the deal structure and runs the competitive process that sets the price, but the advisor does not replace your own CPA and tax attorney. The most efficient outcomes come from those professionals working together early, before a letter of intent is signed, while the structure is still negotiable.

---

Sources

Federal tax authority and IRS guidance

1. Internal Revenue Service. “About Form 8594, Asset Acquisition Statement Under Section 1060.” irs.gov
2. Internal Revenue Service. “Instructions for Form 8594.” irs.gov
3. Internal Revenue Service. “Publication 537 (2025), Installment Sales.” irs.gov
4. Internal Revenue Service. “Publication 544 (2025), Sales and Other Dispositions of Assets.” irs.gov
5. Legal Information Institute, Cornell Law School. “26 U.S. Code § 1060 — Special allocation rules for certain asset acquisitions.” law.cornell.edu
6. Legal Information Institute, Cornell Law School. “26 U.S. Code § 453 — Installment method.” law.cornell.edu
7. Bloomberg Tax. “Sec. 1060. Special Allocation Rules For Certain Asset Acquisitions.” irc.bloombergtax.com

Legal and M&A tax analysis

8. Norton Rose Fulbright. “Section 1060 and Purchase Price Allocations.” 2021. projectfinance.law
9. Mandelbaum Barrett PC. “Understanding Hot Assets in a Veterinary Practice Sale: Tax Implications Every Seller Should Know.” mblawfirm.com
10. Alston & Bird. “Federal Tax Advisory: Equity Rollovers.” 2023. alston.com
11. Frost Brown Todd. “Rollover Equity Transactions.” frostbrowntodd.com
12. Dechert LLP. “Healthcare Investments Flash Alert — Latest Developments.” 2025. dechert.com
13. Holland & Knight. “Q1 Recap on Proposed Legislation Affecting Healthcare Consolidation.” 2026. hklaw.com

Veterinary profession and tax treatment

14. dvm360. “How a practice’s ‘good will’ is valued and taxed.” dvm360.com
15. AVMA. “Just released: AVMA data and insights on the veterinary profession.” avma.org

Capital gains rates and market context

16. Tax Foundation. “2026 Tax Brackets and Federal Income Tax Rates.” taxfoundation.org
17. Kiplinger. “Capital Gains Tax Rates 2025 and 2026: Updated Brackets, Rules and Comparison.” kiplinger.com
18. Octus. “Private-Credit Exposure to Veterinary Rollups Shows Growing Dispersion.” 2025. octus.com
19. Capstone Partners. “Pet Sector M&A Update — April 2026.” capstonepartners.com